Retinal Diseases: From Molecular Pathology to Therapies—2nd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 December 2024 | Viewed by 725
Special Issue Editor
Interests: drug target discovery and drug development for disorders of the CNS and retina; calcium signaling; neuroprotection; neurodegeneration; synaptic signaling; neurophysiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The identification of mechanisms underlying the pathophysiology and therapies of retinal diseases continues to be an area of significant research activity, attracting scientists from a diverse range of fields, including neuroscience, pharmacology, and medicinal chemistry, among several others. With the ultimate goal of generating intervention strategies that slow or even reverse the structural and functional degeneration of the retina and that attenuate or eliminate subsequent vision loss, with input from numerous fields, such as neurology, ophthalmology, genetics, and neuroscience, effective therapies for many retinal diseases are lacking and critically needed.
Research efforts towards preventing, treating, or curing retinal diseases are characteristic for how clinical practice as well as basic and translational research inform each other and how such interactions can result in novel therapeutic strategies of high clinical relevance. Recent methodological advances in synthetic and medicinal chemistry, mass spectrometry, proteomics, drug target discovery, and drug development have generated significant developments in this field. Therefore, this Special Issue invites manuscript submissions, namely research and review papers, targeting the gamut of methodological and scientific innovation in this field. This Special Issue specifically calls for papers focused on the discovery and mechanistic characterization of novel drug targets, signaling pathways, and mechanisms of action, as they are relevant for retinal diseases. These contributions can be general and broad in their basic science, and translational research can focus more on specific research models related to the structural and functional degeneration of the retina and related complications.
Prof. Dr. Peter Koulen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetic retinopathy
- age-related macular degeneration
- neuroprotection
- retina
- diabetic macular edema
- therapy development
- pathophysiology
- retinitis pigmentosa
- aging
- eye trauma
- vitreous
- macula
- choroideremia
- stargardt disease
- cone–rod dystrophy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
